SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Trading Statement

11 May 2022 07:00

RNS Number : 0217L
TP ICAP Group PLC
11 May 2022
Β 

TP ICAP Group plc ("TP ICAP" or the "Group")

Β 

11 May 2022

Β 

Trading update for the three months ended 31 March 2022

Β 

Highlights

Β· Group revenue, excluding Liquidnet, up 3% in constant currency. Including Liquidnet, Group revenue up 14%; growth across all business divisions;

Β· Varied market conditions: Higher level of volatility and trading activity in January / first half of March; more subdued volumes in February and later in March;

Β· We again increased overall market share during the first quarter;

Β· Better revenue mix: growth across all Global Broking asset classes other than Equities (unchanged);

Β· Global Broking revenue per broker up 8%;

Β· Data & Analytics again delivered double-digit revenue growth;

Β· Good progress on transformation programme: TP Interest Rate Options desk now has #2 market share (from #4), benefiting from Fusion deployment.

Β 

Revenue by division

Β 

Three months to31 March

Β 

Β 

2022

Β£m

2021 as reported Β£m

2021 in constant currency Β£m

Reported change

Constant currency change

Global Broking

317

306

309

Β 

Inter-division revenues1

5

5

5

Β 

Total Global Broking

322

311

314

+4%

+3%

Energy & Commodities

106

100

101

Β 

Inter-division revenues1

1

1

1

Β 

Total Energy & Commodities

107

101

102

+6%

+5%

Excluding Liquidnet

27

27

27

0%

0%

Liquidnet2

62

8

8

+675%

+675%

Total Agency Execution

89

35

35

+154%

+154%

Data & Analytics

40

36

36

+11%

+11%

Post-trade Solutions

4

6

6

-33%

-33%

Total Parameta Solutions

44

42

42

+5%

+5%

Inter-division eliminations1

(6)

(6)

(6)

Β 

Total Revenue

556

483

487

+15%

+14%

Total Revenue (excl. Liquidnet)

494

475

479

+4%

+3%

Β 

1. Inter-division charges have been made by Global Broking and Energy & Commodities to reflect the value of proprietary data provided to the Parameta Solutions division. The Global Broking inter-division revenues and Parameta Solutions inter-division costs are eliminated upon the consolidation of the Group's financial results.

2. In Q1 2021, Β£6m of revenue was included within Agency Execution relating to the post-acquisition period of Liquidnet (the acquisition completed on 23 March 2021); This Liquidnet revenue has been restated to Β£8m by including an additional Β£1m of revenue previously reported in Global Broking, and Β£1m previously reported in COEX Partners (in Agency Execution), reflecting the transfer of desks, which, due to their complementary nature and strategic fit, have been reclassified to be managed and reported as part of Liquidnet.

Β 

Revenue by division (constant currency basis):

Β· Global Broking revenue up 3%, benefitting from increased market volatility. Revenue grew in Rates, Credit, FX & Money Markets and Emerging Markets, but was flat in Equities, resulting in an improved mix.

oΒ  Rates activity increased most notably in short-dated contracts, which have lower transaction values compared with longer-dated contracts;

oΒ  Revenue per broker (productivity) improved by 8%.

Β· Energy & Commodities revenue up 5% driven by growth in Oil and Power & Gas in the US, while in Europe, Power & Gas declined, as high prices and significant volatility led to lower volumes.

Β· Agency Execution revenue of Β£89m increased by 154%. Liquidnet revenue of Β£62m was in line with market activity. Market share increased marginally in the US and was stable in Europe, where we remain a market leader.

Β· Parameta Solutions: Continued double-digit revenue growth in Data & Analytics (+11%).

Β 

Strategic progress

Β· Mark Govoni, former President of US Brokerage at Instinet, joined the Group on 2 May 2022 as the new CEO of Agency Execution, with a primary focus on driving the Liquidnet growth strategy;

Β· Parameta Solutions became an FCA authorised benchmark administrator in May: the first inter-dealer broker that will administer over the counter ('OTC') benchmarks;

Β· Digital Assets Spot Platform: Hudson River Trading added to the list of market makers; custodian network expanded to include BitGo and Komainu.

2022 AGM:

Β· The Group will host its Annual General Meeting today, Wednesday 11 May 2022, at 2.15pm (BST) at the offices of Allen & Overy LLP, One Bishop's Square, London, E1 6AD.

Β 

Forward looking statements

This document contains forward looking statements with respect to the financial condition, results and business of the Company. By their nature, forward looking statements involve risk and uncertainty and there may be subsequent variations to estimates. The Company's actual future results may differ materially from the results expressed or implied in these forward-looking statements.

Β 

Β 

Enquiries:

Analysts and investors Dominic LaganDirect: +44 (0) 20 3933 0447

Email: dominic.lagan@tpicap.com

Media Richard NewmanDirect: +44 (0) 7469 039 307

Email: richard.newman@tpicap.com

Β 

Β 

About TP ICAP

Β· TP ICAP connects buyers and sellers in global financial, energy and commodities markets.

Β· It is the world's leading wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world.

Β· We operate from more than 60 offices across 27 countries, supporting brokers with award-winning and market-leading technology.

Β 

Further information on the company and its activities is available on the Company's website: www.tpicap.com

Β 

Β 

TP ICAP Group plc

LEI: 2138006YAA7IRVKKGE63

11 May 2022

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTBBLLFLELEBBB
Date   Source Headline
17th May 20235:05 pmRNSResult of AGM
17th May 20237:00 amRNSTrading Statement
13th Apr 202312:30 pmRNSHolding(s) in Company
5th Apr 20233:00 pmRNSDirector/PDMR Shareholding
4th Apr 202311:00 amRNSNotice of AGM and Committee Membership Changes
3rd Apr 20235:05 pmRNSDirector/PDMR Shareholding
29th Mar 20234:00 pmRNSHolding(s) in Company
23rd Mar 202311:00 amRNSDirector/PDMR Shareholding
22nd Mar 202311:00 amRNS2022 Annual Report and Accounts
14th Mar 20237:00 amRNSTP ICAP Group PLC - Final Results
8th Feb 20234:19 pmRNSChanges to Senior Independent Director
13th Dec 202210:00 amRNSHolding(s) in Company
6th Dec 20225:15 pmRNSHolding(s) in Company
1st Nov 20227:00 amRNSTrading Statement
27th Oct 20225:30 pmRNSHolding(s) in Company
25th Oct 20225:50 pmRNSHolding(s) in Company
13th Sep 20225:32 pmRNSHolding(s) in Company
10th Aug 20227:00 amRNSHalf-year Report
28th Jul 20225:22 pmRNSResult of External Audit Tender
30th Jun 20225:44 pmRNSHolding(s) in Company
27th May 20223:30 pmRNSDirector/PDMR Shareholding
11th May 20226:01 pmRNSResult of AGM
11th May 20227:00 amRNSTrading Statement
4th May 20224:27 pmRNSGrant of Options and Director/PDMR Shareholding
22nd Apr 20224:49 pmRNSHolding(s) in Company
11th Apr 20224:17 pmRNSHolding(s) in Company
5th Apr 202211:02 amRNSAnnual Financial Report
4th Apr 20224:03 pmRNSDirector/PDMR Shareholding
31st Mar 20226:03 pmRNSDirector/PDMR Shareholding
29th Mar 20225:44 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSFinal Results
11th Jan 202211:35 amRNSHolding(s) in Company
22nd Dec 20215:00 pmRNSAppointment of new director
13th Dec 20213:24 pmRNSDirector/PDMR Shareholding
12th Nov 20212:04 pmRNSShareholder meeting update and PDMR transactions
12th Nov 20211:57 pmRNSTotal Voting Rights
2nd Nov 20217:00 amRNSTrading update - three months ended 30/09/2021
11th Oct 20214:00 pmRNSDirector/PDMR Shareholding
11th Oct 20213:01 pmRNSParameta Solutions Investor Seminar
7th Oct 202110:40 amRNSDirector/PDMR Shareholding
20th Sep 20214:58 pmRNSDirector/PDMR Shareholding
8th Sep 20215:08 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSHalf-year Report
3rd Aug 20217:00 amRNSTrading Statement
22nd Jun 20214:36 pmRNSDirector/PDMR Shareholding
18th May 202111:20 amRNSDirector/PDMR Shareholding
12th May 20215:49 pmRNSResult of AGM
12th May 20217:00 amRNSTrading Statement
23rd Apr 20215:10 pmRNSGrant of Options and Director/PDMR Shareholding
6th Apr 20214:32 pmRNSDirector/PDMR Shareholding - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.